Full Press Release Details
WATERTOWN, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events:
Jefferies 2024 Global Healthcare Conference in New York, NY on June 5 at 11:30 a.m. ET; and
Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on June 11 at 2:40 p.m. ET.
Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events.
About Kymera Therapeutics
Investor and Media Contact:
Vice President, Investor Relations
Tags
Targeted Protein Degradation